122 related articles for article (PubMed ID: 20974026)
1. Histological subtypes of prostatic cancer: a comparative survival study.
Kendal WS; Mai KT
Can J Urol; 2010 Oct; 17(5):5355-9. PubMed ID: 20974026
[TBL] [Abstract][Full Text] [Related]
2. Rare Histological Variants of Prostate Adenocarcinoma: A National Cancer Database Analysis.
Bronkema C; Arora S; Sood A; Dalela D; Keeley J; Borchert A; Baumgarten L; Rogers CG; Peabody JO; Menon M; Abdollah F
J Urol; 2020 Aug; 204(2):260-266. PubMed ID: 32141804
[TBL] [Abstract][Full Text] [Related]
3. Histologic variants of adenocarcinoma and other carcinomas of prostate: pathologic criteria and clinical significance.
Randolph TL; Amin MB; Ro JY; Ayala AG
Mod Pathol; 1997 Jun; 10(6):612-29. PubMed ID: 9195581
[TBL] [Abstract][Full Text] [Related]
4. A population-based, descriptive analysis of malignant intraductal papillary mucinous neoplasms of the pancreas.
Le H; Ziogas A; Rhee JM; Lee JG; Lipkin SM; Zell JA
Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2737-41. PubMed ID: 18843017
[TBL] [Abstract][Full Text] [Related]
5. Differences in survival among patients with sarcomatoid carcinoma, carcinosarcoma and urothelial carcinoma of the bladder.
Wright JL; Black PC; Brown GA; Porter MP; Kamat AM; Dinney CP; Lin DW
J Urol; 2007 Dec; 178(6):2302-6; discussion 2307. PubMed ID: 17936803
[TBL] [Abstract][Full Text] [Related]
6. A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma.
Di Saverio S; Gutierrez J; Avisar E
Breast Cancer Res Treat; 2008 Oct; 111(3):541-7. PubMed ID: 18026874
[TBL] [Abstract][Full Text] [Related]
7. Rare and unusual histological variants of prostatic carcinoma: clinical significance.
Mazzucchelli R; Lopez-Beltran A; Cheng L; Scarpelli M; Kirkali Z; Montironi R
BJU Int; 2008 Nov; 102(10):1369-74. PubMed ID: 18793296
[TBL] [Abstract][Full Text] [Related]
8. Prognostic values of clinicopathological characteristics and survival outcomes in prostate infiltrating ductal carcinoma: a population-based study.
Wu YP; Chen SH; Wang ST; Li XD; Cai H; Lin YZ; Xue XY; Wei Y; Zheng QS; Xu N
Oncotarget; 2017 Apr; 8(17):29048-29055. PubMed ID: 28423709
[TBL] [Abstract][Full Text] [Related]
9. Adenocarcinomas of the prostatic duct in necropsy material.
Stamatiou K; Alevizos A; Mariolis A; Fanou D; Alevizou A; Michalodimitrakis E; Sofras F
Can J Urol; 2007 Apr; 14(2):3502-6. PubMed ID: 17466156
[TBL] [Abstract][Full Text] [Related]
10. [Present problems in prostatic carcinoma].
Hohbach M; Dhom G
Munch Med Wochenschr; 1972 Jan; 114(2):45-54. PubMed ID: 4333620
[No Abstract] [Full Text] [Related]
11. Computerized nuclear morphometry: prognostic value for carcinoma of the prostate and renal cell carcinoma.
Wenderoth UK; Gerlach B; Köppen A; Hautmann RE
Investig Urol (Berl); 1994; 5():16-9. PubMed ID: 7719300
[No Abstract] [Full Text] [Related]
12. Genitourinary small cell carcinoma: determination of clinical and therapeutic factors associated with survival.
Mackey JR; Au HJ; Hugh J; Venner P
J Urol; 1998 May; 159(5):1624-9. PubMed ID: 9554367
[TBL] [Abstract][Full Text] [Related]
13. Analysis of factors influencing survival of 109 men with carcinoma of the prostate treated conservatively.
Hand JR
Trans Am Assoc Genitourin Surg; 1973; 65():84-99. PubMed ID: 4763516
[No Abstract] [Full Text] [Related]
14. Uterine carcinosarcomas and grade 3 endometrioid cancers: evidence for distinct tumor behavior.
Bansal N; Herzog TJ; Seshan VE; Schiff PB; Burke WM; Cohen CJ; Wright JD
Obstet Gynecol; 2008 Jul; 112(1):64-70. PubMed ID: 18591309
[TBL] [Abstract][Full Text] [Related]
15. Survival among women with borderline ovarian tumors and ovarian carcinoma: a population-based analysis.
Sherman ME; Mink PJ; Curtis R; Cote TR; Brooks S; Hartge P; Devesa S
Cancer; 2004 Mar; 100(5):1045-52. PubMed ID: 14983501
[TBL] [Abstract][Full Text] [Related]
16. [Course of prostate cancer].
Heinrichs HJ; Hasselbacher K
Z Urol Nephrol; 1980 Oct; 73(10):737-9. PubMed ID: 6256993
[TBL] [Abstract][Full Text] [Related]
17. Rare prostatic carcinomas: histogenesis and morphologic pattern.
Losi L; Brausi M; Di Gregorio C
Pathologica; 1994 Aug; 86(4):366-70. PubMed ID: 7708435
[TBL] [Abstract][Full Text] [Related]
18. Differences in survival by histologic type of pancreatic cancer.
Fesinmeyer MD; Austin MA; Li CI; De Roos AJ; Bowen DJ
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1766-73. PubMed ID: 16030115
[TBL] [Abstract][Full Text] [Related]
19. Loose seeds versus stranded seeds in I-125 prostate brachytherapy: differences in clinical outcome.
Hinnen KA; Moerland MA; Battermann JJ; van Roermund JG; Monninkhof EM; Jürgenliemk-Schulz IM; van Vulpen M
Radiother Oncol; 2010 Jul; 96(1):30-3. PubMed ID: 20215039
[TBL] [Abstract][Full Text] [Related]
20. Surveillance, Epidemiology, and End Results (SEER) database analysis of microcystic adnexal carcinoma (sclerosing sweat duct carcinoma) of the skin.
Yu JB; Blitzblau RC; Patel SC; Decker RH; Wilson LD
Am J Clin Oncol; 2010 Apr; 33(2):125-7. PubMed ID: 19675445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
